Linking of metabolomic biomarkers with cardiometabolic health in Chinese population
文献类型：期刊论文
| 作者 | Sun, Liang; Li, Huaixing; Lin, Xu |
| 刊名 | JOURNAL OF DIABETES
 |
| 出版日期 | 2019 |
| 卷号 | 11期号:4页码:280-291 |
| ISSN号 | 1753-0393 |
| 关键词 | biomarkers cardiometabolic diseases Chinese metabolomics |
| DOI | 10.1111/1753-0407.12858 |
| 文献子类 | Review |
| 英文摘要 | Due to rapid nutrition transitions, the prevalence of cardiometabolic diseases, such as metabolic syndrome, type 2 diabetes, and cardiovascular diseases, has been increasing at an alarming rate in the Chinese population. Moreover, Asians, including Chinese, have been hypothesized to have a higher susceptibility to cardiometabolic diseases than Caucasians. Early prediction and prevention are key to controlling this epidemic trend; to this end, the identification of novel biomarkers is critical to reflect environmental exposure, as well as to reveal endogenous metabolic and pathophysiologic mechanisms. The emerging "omics" technologies, especially metabolomics, offer a unique opportunity to provide novel signatures or fingerprints to understand the effects of genetic and non-genetic factors on cardiometabolic health. During the past two decades, metabolomic approaches have been increasingly used in various epidemiological studies, primarily in Western populations. Although the field is still in its early stages, some studies have tried to identify novel compounds or confirm their metabolites and associations with cardiometabolic diseases in Chinese populations, including amino acids, fatty acids, acylcarnitines and other metabolites. Despite major efforts to discover novel biomarkers for disease prediction or intervention, the limits in current study design, analytical platforms, and data processing approaches are challenges in metabolomic research worldwide. Therefore, future research with more advanced technologies, rigorous study designs, standardized detection and analytic approaches, and integrated data from multiomics approaches are essential to evaluate the feasibility of using metabolomics in clinical settings. Finally, the functional roles and underlying biological mechanisms of metabolomic biomarkers should be elucidated by future mechanistic research. |
| 学科主题 | Endocrinology & Metabolism |
| WOS关键词 | TYPE-2 DIABETES-MELLITUS ; POLYUNSATURATED FATTY-ACIDS ; GENOME-WIDE ASSOCIATION ; PLASMA ACYLCARNITINES ; RISK-FACTORS ; CARDIOVASCULAR-DISEASE ; MYOCARDIAL-INFARCTION ; MASS-SPECTROMETRY ; BRANCHED-CHAIN ; WEIGHT-LOSS |
| 语种 | 英语 |
| 出版者 | WILEY |
| WOS记录号 | WOS:000460354900005 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.144/handle/331004/484]  |
| 专题 | 中国科学院上海生命科学研究院营养科学研究所 |
| 作者单位 | Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth,CAS Key Lab Nutr Metab, Shanghai, Peoples R China, |
| 推荐引用方式 GB/T 7714 | Sun, Liang,Li, Huaixing,Lin, Xu. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population[J]. JOURNAL OF DIABETES,2019,11(4):280-291. |
| APA | Sun, Liang,Li, Huaixing,&Lin, Xu.(2019).Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.JOURNAL OF DIABETES,11(4),280-291. |
| MLA | Sun, Liang,et al."Linking of metabolomic biomarkers with cardiometabolic health in Chinese population".JOURNAL OF DIABETES 11.4(2019):280-291. |
入库方式： OAI收割
来源：上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。